Works by Gallego, Jaime


Results: 94
    1

    A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.

    Published in:
    2017
    By:
    • Inogés, Susana;
    • Tejada, Sonia;
    • de Cerio, Ascensión López-Díaz;
    • Pérez-Larraya, Jaime Gállego;
    • Espinós, Jaime;
    • Idoate, Miguel Angel;
    • Domínguez, Pablo Daniel;
    • de Eulate, Reyes García;
    • Aristu, Javier;
    • Bendandi, Maurizio;
    • Pastor, Fernando;
    • Alonso, Marta;
    • Andreu, Enrique;
    • Cardoso, Felipe Prósper;
    • Valle, Ricardo Díez;
    • Gállego Pérez-Larraya, Jaime
    Publication type:
    journal article
    2
    3

    Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2023, v. 80, n. 8, p. 779, doi. 10.1001/jamaneurol.2023.1660
    By:
    • Hernández-Jiménez, Macarena;
    • Abad-Santos, Francisco;
    • Cotgreave, Ian;
    • Gallego, Jaime;
    • Jilma, Bernd;
    • Flores, Alan;
    • Jovin, Tudor G.;
    • Vivancos, José;
    • Hernández-Pérez, María;
    • Molina, Carlos A.;
    • Montaner, Joan;
    • Casariego, Joaquín;
    • Dalsgaard, Mads;
    • Liebeskind, David S.;
    • Cobo, Erik;
    • Castellanos, Mar;
    • Portela, Pere Cardona;
    • Masjuán, Jaime;
    • Moniche, Francisco;
    • Tembl, José Ignacio
    Publication type:
    Article
    4
    5
    6

    An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas.

    Published in:
    BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/282815
    By:
    • Laffaire, Julien;
    • Di Stefano, Anna Luisa;
    • Chinot, Olivier;
    • Idbaih, Ahmed;
    • Perez-Larraya, Jaime Gallego;
    • Marie, Yannick;
    • Vintonenko, Nadia;
    • Boisselier, Blandine;
    • Farina, Patrizia;
    • Delattre, Jean-Yves;
    • Figarella-Branger, Dominique;
    • Honnorat, Jérôme;
    • Sanson, Marc;
    • Ducray, François
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Leveraging lessons learned to prevent future disasters—insights from the 2013 Colombia-US binational exchange.

    Published in:
    Journal of Applied Volcanology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s13617-019-0090-8
    By:
    • Driedger, Carolyn;
    • Calvache, Marta;
    • Cortés, Gloria Patricia;
    • Ewert, John;
    • Montoya, Jacqueline;
    • Lockhart, Andy;
    • Allen, Robert;
    • Banks, Daniel;
    • Beason, Scott;
    • Bocanegra, Harold Trujillo;
    • Burkhart, Frances;
    • Bustad, Kyle;
    • Gallego, Jaime Andres;
    • Gibson, Zane;
    • Giraldo, Felix Ricardo;
    • Gutierrez, Cesar;
    • Quintero, Jorge Ivan;
    • Rodríguez, Eduardo;
    • Schelling, John;
    • Scott, Marci
    Publication type:
    Article
    15

    P-155: Incidence, mitigation, and management of neurologic adverse events in CARTITUDE-2, a phase 2 study of ciltacabtagene autoleucel (cilta-cel) in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S120, doi. 10.1016/S2152-2650(21)02282-5
    By:
    • Einsele, Hermann;
    • Parekh, Samir;
    • Madduri, Deepu;
    • Santomasso, Bianca;
    • Pérez-Larraya, Jaime Gállego;
    • van de Donk, Niels W.C.J.;
    • Arnulf, Bertrand;
    • Mateos, María-Victoria;
    • De Braganca, Kevin C.;
    • Varsos, Helen;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Lendvai, Nikoletta;
    • Jackson, Carolyn C.;
    • Olyslager, Yunsi;
    • Zudaire, Enrique;
    • Li, Claire;
    • Dong Geng;
    • Jakubowiak, Andrzej;
    • Cohen, Adam
    Publication type:
    Article
    16

    MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S421, doi. 10.1016/S2152-2650(21)01945-5
    By:
    • Jakubowiak, Andrzej;
    • Parekh, Samir;
    • Madduri, Deepu;
    • Santomasso, Bianca;
    • Pérez-Larraya, Jaime Gállego;
    • van de Donk, Niels W.C.J.;
    • Arnulf, Bertrand;
    • Mateos, Maria-Victoria;
    • De Braganca, Kevin C.;
    • Varsos, Helen;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Lendvai, Nikoletta;
    • Jackson, Carolyn C.;
    • Olyslager, Yunsi;
    • Zudaire, Enrique;
    • Li, Claire;
    • Geng, Dong;
    • Einsele, Hermann;
    • Cohen, Adam
    Publication type:
    Article
    17

    Poster: MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S249, doi. 10.1016/S2152-2650(21)01568-8
    By:
    • Jakubowiak, Andrzej;
    • Parekh, Samir;
    • Madduri, Deepu;
    • Santomasso, Bianca;
    • Pérez-Larraya, Jaime Gállego;
    • van de Donk, Niels W.C.J.;
    • Arnulf, Bertrand;
    • Mateos, Maria-Victoria;
    • De Braganca, Kevin C.;
    • Varsos, Helen;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Lendvai, Nikoletta;
    • Jackson, Carolyn C.;
    • Olyslager, Yunsi;
    • Zudaire, Enrique;
    • Li, Claire;
    • Geng, Dong;
    • Einsele, Hermann;
    • Cohen, Adam
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26

    VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 121, n. 3, p. 499, doi. 10.1007/s11060-014-1677-x
    By:
    • Stefano, Anna;
    • Labussiere, Marianne;
    • Lombardi, Giuseppe;
    • Eoli, Marica;
    • Bianchessi, Donata;
    • Pasqualetti, Francesco;
    • Farina, Patrizia;
    • Cuzzubbo, Stefania;
    • Gallego-Perez-Larraya, Jaime;
    • Boisselier, Blandine;
    • Ducray, Francois;
    • Cheneau, Caroline;
    • Moglia, Arrigo;
    • Finocchiaro, Gaetano;
    • Marie, Yannick;
    • Rahimian, Amithys;
    • Hoang-Xuan, Khe;
    • Delattre, Jean;
    • Mokhtari, Karima;
    • Sanson, Marc
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    GenSeed-HMM: A Tool for Progressive Assembly Using Profile HMMs as Seeds and its Application in Alpavirinae Viral Discovery from Metagenomic Data.

    Published in:
    Frontiers in Microbiology, 2016, p. 1, doi. 10.3389/fmicb.2016.00269
    By:
    • Alves, João M. P.;
    • De Oliveira, André L.;
    • Sandberg, Tatiana O. M.;
    • Moreno-Gallego, Jaime L.;
    • De Toledo, Marcelo A. F.;
    • De Moura, Elisabeth M. M.;
    • Oliveira, Liliane S.;
    • Durham, Alan M.;
    • Mehnert, Dolores U.;
    • De A. Zanotto, Paolo M.;
    • Reyes, Alejandro;
    • Gruber, Arthur
    Publication type:
    Article
    38

    Circular RNA expression profile in blood according to ischemic stroke etiology.

    Published in:
    Cell & Bioscience, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13578-020-00394-3
    By:
    • Ostolaza, Aiora;
    • Blanco-Luquin, Idoia;
    • Urdánoz-Casado, Amaya;
    • Rubio, Idoya;
    • Labarga, Alberto;
    • Zandio, Beatriz;
    • Roldán, Miren;
    • Martínez-Cascales, Judith;
    • Mayor, Sergio;
    • Herrera, María;
    • Aymerich, Nuria;
    • Gallego, Jaime;
    • Muñoz, Roberto;
    • Mendioroz, Maite
    Publication type:
    Article
    39

    Dendritic Cells in Cancer Immunology and Immunotherapy.

    Published in:
    Cancers, 2024, v. 16, n. 5, p. 981, doi. 10.3390/cancers16050981
    By:
    • Hato, Laura;
    • Vizcay, Angel;
    • Eguren, Iñaki;
    • Pérez-Gracia, José L.;
    • Rodríguez, Javier;
    • Gállego Pérez-Larraya, Jaime;
    • Sarobe, Pablo;
    • Inogés, Susana;
    • Díaz de Cerio, Ascensión López;
    • Santisteban, Marta
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50